Published in J Clin Invest on October 25, 2010
Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol (2013) 3.38
Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat Rev Immunol (2013) 2.38
First do no harm: uterine natural killer (NK) cells in assisted reproduction. Hum Reprod (2015) 2.14
Pros and cons for C4d as a biomarker. Kidney Int (2012) 2.03
Major histocompatibility complex genomics and human disease. Annu Rev Genomics Hum Genet (2013) 1.75
Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors. Genome Res (2012) 1.60
Paternal MHC expression on mouse trophoblast affects uterine vascularization and fetal growth. Proc Natl Acad Sci U S A (2011) 1.59
Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules. Philos Trans R Soc Lond B Biol Sci (2012) 1.55
Organ-specific features of natural killer cells. Nat Rev Immunol (2011) 1.48
Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation. J Clin Invest (2013) 1.36
Physiological and molecular determinants of embryo implantation. Mol Aspects Med (2013) 1.33
Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling. Proc Natl Acad Sci U S A (2012) 1.29
KIR/HLA interactions and pathogen immunity. J Biomed Biotechnol (2011) 1.26
Uterine NK cells: active regulators at the maternal-fetal interface. J Clin Invest (2014) 1.23
Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3. J Immunol (2012) 1.19
Genetics of recurrent miscarriage: challenges, current knowledge, future directions. Front Genet (2012) 1.16
A KIR B centromeric region present in Africans but not Europeans protects pregnant women from pre-eclampsia. Proc Natl Acad Sci U S A (2015) 1.11
MHC-dependent inhibition of uterine NK cells impedes fetal growth and decidual vascular remodelling. Nat Commun (2014) 1.10
Genome-wide expression profile of first trimester villous and extravillous human trophoblast cells. Placenta (2010) 1.08
Conversion of peripheral blood NK cells to a decidual NK-like phenotype by a cocktail of defined factors. J Immunol (2013) 1.07
Extravillous trophoblast and decidual natural killer cells: a remodelling partnership. Hum Reprod Update (2012) 1.06
A database for curating the associations between killer cell immunoglobulin-like receptors and diseases in worldwide populations. Database (Oxford) (2013) 1.05
HLA-C as a mediator of natural killer and T-cell activation: spectator or key player? Immunology (2011) 1.05
TLR/NCR/KIR: Which One to Use and When? Front Immunol (2014) 1.03
The effect of pregnancy on the uterine NK cell KIR repertoire. Eur J Immunol (2011) 1.02
HLA-G-mediated NK cell senescence promotes vascular remodeling: implications for reproduction. Cell Mol Immunol (2014) 1.02
Impaired decidual natural killer cell regulation of vascular remodelling in early human pregnancies with high uterine artery resistance. J Pathol (2012) 1.01
Maternal KIR in combination with paternal HLA-C2 regulate human birth weight. J Immunol (2014) 1.01
Virus encoded MHC-like decoys diversify the inhibitory KIR repertoire. PLoS Comput Biol (2013) 1.00
Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3. Front Immunol (2012) 0.99
Pregnancy, parturition and preeclampsia in women of African ancestry. Am J Obstet Gynecol (2013) 0.97
NK cells and psoriasis. J Biomed Biotechnol (2011) 0.97
MicroRNAs, immune cells and pregnancy. Cell Mol Immunol (2014) 0.97
The placenta: a multifaceted, transient organ. Philos Trans R Soc Lond B Biol Sci (2015) 0.96
How does variability of immune system genes affect placentation? Placenta (2011) 0.96
Pregnancy immunogenetics: NK cell education in the womb? J Clin Invest (2010) 0.96
Relationship between maternal immunological response during pregnancy and onset of preeclampsia. J Immunol Res (2014) 0.95
Decidual natural killer cell interactions with trophoblasts are impaired in pregnancies at increased risk of preeclampsia. Am J Pathol (2013) 0.95
Activating killer cell Ig-like receptors in health and disease. Front Immunol (2014) 0.95
Killer cell immunoglobulin-like receptor (KIR) genes and their HLA-C ligands in a Ugandan population. Immunogenetics (2013) 0.93
Cytomegalovirus impairs cytotrophoblast-induced lymphangiogenesis and vascular remodeling in an in vivo human placentation model. Am J Pathol (2012) 0.93
EBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail. J Immunol (2013) 0.93
HIV-1 Vpu Mediates HLA-C Downregulation. Cell Host Microbe (2016) 0.93
Review: Immunogenetics of human placentation. Placenta (2011) 0.92
The evolution of natural killer cell receptors. Immunogenetics (2015) 0.92
Disrupted balance of angiogenic and antiangiogenic signalings in preeclampsia. J Pregnancy (2011) 0.91
The role of the maternal immune system in the regulation of human birthweight. Philos Trans R Soc Lond B Biol Sci (2015) 0.91
Innate and adaptive immune interactions at the fetal-maternal interface in healthy human pregnancy and pre-eclampsia. Front Immunol (2014) 0.91
Embryonic trophoblasts induce decidual regulatory T cell differentiation and maternal-fetal tolerance through thymic stromal lymphopoietin instructing dendritic cells. J Immunol (2014) 0.90
The up side of decidual natural killer cells: new developments in immunology of pregnancy. Immunology (2014) 0.90
Immune mechanisms at the maternal-fetal interface: perspectives and challenges. Nat Immunol (2015) 0.89
Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations. Front Immunol (2016) 0.89
The role of invasive trophoblast in implantation and placentation of primates. Philos Trans R Soc Lond B Biol Sci (2015) 0.88
Trophoblasts, invasion, and microRNA. Front Genet (2013) 0.88
The structural basis of ligand recognition by natural killer cell receptors. J Biomed Biotechnol (2011) 0.87
Dendritic cell function at the maternal-fetal interface. Expert Rev Clin Immunol (2011) 0.87
Signatures of historical demography and pathogen richness on MHC class I genes. Immunogenetics (2011) 0.87
Maternal-fetal HLA sharing and preeclampsia: variation in effects by seminal fluid exposure in a case-control study of nulliparous women in Iowa. J Reprod Immunol (2013) 0.87
Molecular evidence for natural killer-like cells in equine endometrial cups. Placenta (2012) 0.87
Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection. Am J Reprod Immunol (2011) 0.86
DAP12 impacts trafficking and surface stability of killer immunoglobulin-like receptors on natural killer cells. J Leukoc Biol (2013) 0.86
Maternal floor infarction/massive perivillous fibrin deposition: a manifestation of maternal antifetal rejection? Am J Reprod Immunol (2013) 0.86
Natural killer cells and regulatory T cells in early pregnancy loss. Int J Dev Biol (2014) 0.86
Decidual cell regulation of natural killer cell-recruiting chemokines: implications for the pathogenesis and prediction of preeclampsia. Am J Pathol (2013) 0.85
Evaluation of KIR genes in recurrent miscarriage. J Assist Reprod Genet (2012) 0.85
Ly49 receptors activate angiogenic mouse DBA⁺ uterine natural killer cells. Cell Mol Immunol (2014) 0.84
Local and systemic factors and implantation: what is the evidence? Fertil Steril (2016) 0.84
Tissue-specific effector functions of innate lymphoid cells. Immunology (2013) 0.84
Role of KIR3DS1 in human diseases. Front Immunol (2012) 0.83
Killer cell immunoglobulin-like receptor gene associations with autoimmune and allergic diseases, recurrent spontaneous abortion, and neoplasms. Front Immunol (2013) 0.83
Hypertension persisting after pre-eclampsia: a prospective cohort study at Mulago Hospital, Uganda. PLoS One (2013) 0.82
The T helper type 17/regulatory T cell paradigm in pregnancy. Immunology (2016) 0.82
Tissue-Specific Education of Decidual NK Cells. J Immunol (2015) 0.81
NK cells, hypoxia and trophoblast cell differentiation. Cell Cycle (2012) 0.81
Receptors for non-MHC ligands contribute to uterine natural killer cell activation during pregnancy in mice. Placenta (2013) 0.81
The role of KIR and HLA interactions in pregnancy complications. Immunogenetics (2017) 0.81
Reproduction, infection and killer-cell immunoglobulin-like receptor haplotype evolution. Immunogenetics (2016) 0.80
Time to seroconversion in HIV-exposed subjects carrying protective versus non protective KIR3DS1/L1 and HLA-B genotypes. PLoS One (2014) 0.80
Activating KIR2DS4 Is Expressed by Uterine NK Cells and Contributes to Successful Pregnancy. J Immunol (2016) 0.80
Missing or altered self: human NK cell receptors that recognize HLA-C. Immunogenetics (2017) 0.79
Demystifying animal models of adverse pregnancy outcomes: touching bench and bedside. Am J Reprod Immunol (2013) 0.79
Decidual natural killer cell receptor expression is altered in pregnancies with impaired vascular remodeling and a higher risk of pre-eclampsia. J Leukoc Biol (2014) 0.79
The Size of Activating and Inhibitory Killer Ig-like Receptor Nanoclusters Is Controlled by the Transmembrane Sequence and Affects Signaling. Cell Rep (2016) 0.79
The role of the invasive, placental trophoblast in human pregnancy. Wien Med Wochenschr (2012) 0.79
Deciphering the KIR system at super-resolution for NK and T cell biology. Immunology (2016) 0.79
Immunogenetic contributions to recurrent pregnancy loss. J Assist Reprod Genet (2016) 0.79
Killer immunoglobulin-like receptor gene repertoire influences viral load of primary human cytomegalovirus infection in renal transplant patients. Genes Immun (2014) 0.78
Complex MHC Class I Gene Transcription Profiles and Their Functional Impact in Orangutans. J Immunol (2015) 0.78
Future directions of clinical laboratory evaluation of pregnancy. Cell Mol Immunol (2014) 0.78
HLA class I expression in the human placenta. Wien Med Wochenschr (2012) 0.78
PD-1 and Tim-3 pathways are associated with regulatory CD8+ T-cell function in decidua and maintenance of normal pregnancy. Cell Death Dis (2015) 0.78
Pregnancy close to the edge: an immunosuppressive infiltrate in the chorionic plate of placentas from uncomplicated egg cell donation. PLoS One (2012) 0.77
Uterine Natural Killer Cells: Functional Distinctions and Influence on Pregnancy in Humans and Mice. Front Immunol (2017) 0.76
Human Birth Weight and Reproductive Immunology: Testing for Interactions between Maternal and Offspring KIR and HLA-C Genes. Hum Hered (2017) 0.76
Function and control of human invasive trophoblast subtypes: Intrinsic vs. maternal control. Cell Adh Migr (2015) 0.76
Ligand specificity of Killer cell Immunoglobulin-like Receptors: a brief history of KIR. Front Immunol (2012) 0.76
Natural Killer Cell Diversity in Viral Infection: Why and How Much? Pathog Immun (2016) 0.76
Cytotoxic potential of decidual NK cells and CD8+ T cells awakened by infections. J Reprod Immunol (2016) 0.76
KIR2DS5 allotypes that recognize the C2 epitope of HLA-C are common among Africans and absent from Europeans. Immun Inflamm Dis (2017) 0.75
Strangers no more: uterine NK cell recognition of the placenta in mice. Proc Natl Acad Sci U S A (2011) 0.75
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science (2004) 8.22
MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol (2005) 6.98
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet (2007) 6.83
Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med (2006) 6.54
Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood (2010) 4.46
Natural killer cells and pregnancy. Nat Rev Immunol (2002) 4.21
Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med (2007) 4.14
Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med (2001) 4.02
Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med (2004) 3.87
Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med (2003) 3.46
Immunology of placentation in eutherian mammals. Nat Rev Immunol (2006) 3.43
The uterine spiral arteries in human pregnancy: facts and controversies. Placenta (2006) 3.34
New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens (2003) 3.30
Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia. Blood (2008) 3.18
HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet (2009) 3.03
Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood (2009) 2.88
Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol (1998) 2.79
Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J Immunol (2008) 2.76
MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response. Blood (2008) 2.71
Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci U S A (2005) 2.55
Influence of past reproductive performance on risk of spontaneous abortion. BMJ (1989) 2.44
The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet (2006) 2.43
Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol (2002) 2.38
Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta (2009) 2.37
Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig (2004) 2.33
The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev (2002) 2.21
Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol (2006) 2.15
Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum Reprod (2008) 2.06
Recurrent miscarriage: aetiology, management and prognosis. Hum Reprod Update (2002) 2.00
NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol (2009) 2.00
KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. J Exp Med (2009) 1.99
Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc Natl Acad Sci U S A (2005) 1.82
Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells. Immunol Rev (2008) 1.74
TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr Biol (1998) 1.70
Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ (2005) 1.70
Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia. Placenta (2008) 1.67
Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology (2009) 1.61
Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family. Crit Rev Immunol (2002) 1.52
The impact of variation at the KIR gene cluster on human disease. Curr Top Microbiol Immunol (2006) 1.46
KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro. J Immunol (2007) 1.43
Immature NK cells, capable of producing IL-22, are present in human uterine mucosa. J Immunol (2010) 1.41
Expression of killer cell inhibitory receptors on human uterine natural killer cells. Eur J Immunol (1997) 1.37
Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells. Int Immunol (2008) 1.36
The genetic and evolutionary balances in human NK cell receptor diversity. Semin Immunol (2008) 1.35
Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands. Proc Natl Acad Sci U S A (2009) 1.35
Killer Ig-like receptor expression in uterine NK cells is biased toward recognition of HLA-C and alters with gestational age. J Immunol (2008) 1.30
Dramatically reduced surface expression of NK cell receptor KIR2DS3 is attributed to multiple residues throughout the molecule. Genes Immun (2008) 1.28
Pathophysiology of histological changes in early pregnancy loss. Placenta (2005) 1.17
Predicting adverse obstetric outcome after early pregnancy events and complications: a review. Hum Reprod Update (2009) 1.12
Defective haemochorial placentation as a cause of miscarriage: a preliminary study. Br J Obstet Gynaecol (1987) 1.11
KIR haplotypes defined by segregation analysis in 59 Centre d'Etude Polymorphisme Humain (CEPH) families. Immunogenetics (2008) 1.10
Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules. Hum Immunol (2003) 1.10
Human monoclonal HLA antibodies reveal interspecies crossreactive swine MHC class I epitopes relevant for xenotransplantation. Mol Immunol (2009) 1.08
TLRs mediate IFN-gamma production by human uterine NK cells in endometrium. J Immunol (2006) 1.05
Natural killer cells in human pregnancy. Methods Mol Biol (2010) 1.03
KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals. Int Immunol (2008) 1.01
Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies. Immunology (2009) 1.01
The effect of recurrent miscarriage and infertility on the risk of pre-eclampsia. BJOG (2009) 0.98
Autologous and allogeneic HLA KIR ligand environments and activating KIR control KIR NK-cell functions. Eur J Immunol (2008) 0.97
Conformation of human leucocyte antigen-C molecules at the surface of human trophoblast cells. Immunology (2008) 0.93
Effect of the IgM and IgA secretory tailpieces on polymerization and secretion of IgM and IgG. J Immunol (1996) 0.87
A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet (2006) 15.63
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature (2009) 13.99
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science (2004) 8.22
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet (2002) 7.58
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet (2007) 6.83
The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J Virol (2006) 4.26
Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration. J Infect Dis (2012) 4.24
Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med (2009) 4.22
HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1. PLoS Med (2006) 4.19
Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med (2007) 4.14
Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol (2007) 4.04
HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med (2011) 3.93
Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med (2004) 3.87
Recurrent miscarriage. Lancet (2006) 3.86
Common genetic variation and the control of HIV-1 in humans. PLoS Genet (2009) 3.68
Mamu-B*08-positive macaques control simian immunodeficiency virus replication. J Virol (2007) 3.61
Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection. Nature (2010) 3.57
Influence of HLA-C expression level on HIV control. Science (2013) 3.27
Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes. Nat Immunol (2005) 3.23
Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet (2010) 3.15
HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet (2009) 3.03
Human chromosome 7: DNA sequence and biology. Science (2003) 3.02
AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med (2005) 2.97
Host determinants of HIV-1 control in African Americans. J Infect Dis (2010) 2.90
Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. Gastroenterology (2008) 2.83
Genetic analysis of completely sequenced disease-associated MHC haplotypes identifies shuffling of segments in recent human history. PLoS Genet (2006) 2.80
BRACHYURY and CDX2 mediate BMP-induced differentiation of human and mouse pluripotent stem cells into embryonic and extraembryonic lineages. Cell Stem Cell (2011) 2.79
Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. J Invest Dermatol (2013) 2.74
A Randomized Trial of Progesterone in Women with Recurrent Miscarriages. N Engl J Med (2015) 2.73
The Yin and Yang of HLA and KIR in human disease. Semin Immunol (2008) 2.72
High-resolution patterns of meiotic recombination across the human major histocompatibility complex. Am J Hum Genet (2002) 2.71
The shaping of modern human immune systems by multiregional admixture with archaic humans. Science (2011) 2.63
HIV-1 adaptation to NK-cell-mediated immune pressure. Nature (2011) 2.59
Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells. J Virol (2009) 2.51
The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet (2006) 2.43
Global diversity and evidence for coevolution of KIR and HLA. Nat Genet (2007) 2.40
Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat Rev Immunol (2013) 2.38
Coordinate linkage of HIV evolution reveals regions of immunological vulnerability. Proc Natl Acad Sci U S A (2011) 2.37
Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature (2011) 2.36
An integrated haplotype map of the human major histocompatibility complex. Am J Hum Genet (2003) 2.29
Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol (2007) 2.28
MRI guidance of focused ultrasound therapy of uterine fibroids: early results. AJR Am J Roentgenol (2004) 2.19
Genetics of cleft lip and palate: syndromic genes contribute to the incidence of non-syndromic clefts. Hum Mol Genet (2004) 2.18
Exploration and confirmation of factors associated with uncomplicated pregnancy in nulliparous women: prospective cohort study. BMJ (2013) 2.10
Screening for thrombophilia in high-risk situations: a meta-analysis and cost-effectiveness analysis. Br J Haematol (2005) 2.10
KIR and disease: a model system or system of models? Immunol Rev (2006) 2.07
KIR/HLA pleiotropism: protection against both HIV and opportunistic infections. PLoS Pathog (2006) 2.06
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes. Proc Natl Acad Sci U S A (2007) 2.04
HLA class I subtype-dependent expansion of KIR3DS1+ and KIR3DL1+ NK cells during acute human immunodeficiency virus type 1 infection. J Virol (2009) 2.03
Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission. Virology (2004) 2.00
Next-generation sequencing for HLA typing of class I loci. BMC Genomics (2011) 1.99
Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol (2002) 1.95
Balanced polymorphism selected by genetic versus infectious human disease. Annu Rev Genomics Hum Genet (2002) 1.93
Leukocyte extravasation: chemokine transport and presentation by the endothelium. Blood (2002) 1.92
The long-term outcome in surviving infants with Apgar zero at 10 minutes: a systematic review of the literature and hospital-based cohort. Am J Obstet Gynecol (2007) 1.92
Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort. BMJ (2011) 1.88
An association between variants in the IGF2 gene and Beckwith-Wiedemann syndrome: interaction between genotype and epigenotype. Hum Mol Genet (2003) 1.85
Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol (2004) 1.83
HLA-Cw*04 and hepatitis C virus persistence. J Virol (2002) 1.83
Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med (2013) 1.82
Adjunctive passive immunotherapy in human immunodeficiency virus type 1-infected individuals treated with antiviral therapy during acute and early infection. J Virol (2007) 1.81
Conserved methylation imprints in the human and mouse GRB10 genes with divergent allelic expression suggests differential reading of the same mark. Hum Mol Genet (2003) 1.80
Identification of the imprinted KLF14 transcription factor undergoing human-specific accelerated evolution. PLoS Genet (2007) 1.79
Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol (2007) 1.78
High HLA-DP Expression and Graft-versus-Host Disease. N Engl J Med (2015) 1.74
The importance of imprinting in the human placenta. PLoS Genet (2010) 1.74
The primate-specific microRNA gene cluster (C19MC) is imprinted in the placenta. Hum Mol Genet (2010) 1.73
CCL3L1 and HIV/AIDS susceptibility. Nat Med (2009) 1.73
Peptide antagonism as a mechanism for NK cell activation. Proc Natl Acad Sci U S A (2010) 1.72
DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. J Exp Med (2003) 1.70
HLA/KIR restraint of HIV: surviving the fittest. Annu Rev Immunol (2011) 1.66
A screen for retrotransposed imprinted genes reveals an association between X chromosome homology and maternal germ-line methylation. PLoS Genet (2006) 1.66
Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin-related molecule: effects on HIV-1 susceptibility. J Infect Dis (2006) 1.62
Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology (2009) 1.61
Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression. PLoS Genet (2008) 1.60
Rhesus macaque dendritic cells efficiently transmit primate lentiviruses independently of DC-SIGN. Proc Natl Acad Sci U S A (2002) 1.59
Paternal MHC expression on mouse trophoblast affects uterine vascularization and fetal growth. Proc Natl Acad Sci U S A (2011) 1.59
Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies. J Infect Dis (2002) 1.58
Waddlia chondrophila, a potential agent of human fetal death. Emerg Infect Dis (2007) 1.57
Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology. Blood (2010) 1.56
Evidence for a selective migration of fetus-specific CD4+CD25bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. J Immunol (2008) 1.56
Germline melanocortin-1-receptor genotype is associated with severity of cutaneous phenotype in congenital melanocytic nevi: a role for MC1R in human fetal development. J Invest Dermatol (2012) 1.56
Single haplotype analysis demonstrates rapid evolution of the killer immunoglobulin-like receptor (KIR) loci in primates. Genome Res (2005) 1.56
Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects. PLoS Genet (2013) 1.55
Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell-mediated lysis of myeloma. Blood (2007) 1.55
Risk factors for macrosomia and its clinical consequences: a study of 350,311 pregnancies. Eur J Obstet Gynecol Reprod Biol (2003) 1.55
A critical look at HLA-G. Trends Immunol (2008) 1.55